Ledger.Open graph →
SEC Form D · Amendment · filed March 2, 2022

Sudo Biosciences, Inc

Offering
$22.3M
Sold
$22.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Daniel Estes · Menlo Park, CADirectorJim Bristol · Menlo Park, CADirectorScott Byrd · Menlo Park, CAExec · DirectorOnePointTwo Capital Management LLC · Albany, NYExec · DirectorOnePointTwo Capital Performance LLC · Albany, NYDirectorSame Zanbato Capital LLC · Mountain View, CADirectorTom H. Turi · Broomfield, CODirectorDouglas Davenport · Germantown, TNDirectorJohn Ormiston · Rancho Santa Margarita, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗